| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.810 | 0 | 0 | 52.353 | 9.843 | 413 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 25.811 | 0 | 0 | 52.353 | 9.843 | 414 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 20.702 | 5.892 | 1.188 | 37.859 | 27.538 | 876 | 158 | 15.421 | 0 | 0 |
| Gross Profit/Loss - EUR | 5.109 | -5.892 | -1.188 | 14.495 | -17.694 | -462 | -158 | -15.421 | 0 | 0 |
| Net Profit/Loss - EUR | 4.335 | -5.892 | -1.188 | 13.521 | -17.793 | -475 | -158 | -15.421 | 0 | 0 |
| Employees | 4 | 0 | 0 | 4 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Conas Bioana S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 25.564 | 22.655 | 22.272 | 21.016 | 18.137 | 17.793 | 17.399 | 2.097 | 2.091 | 0 |
| Current Assets | 26.785 | 6.240 | 4.543 | 28.236 | 9.263 | 5.898 | 5.606 | 5.558 | 5.535 | 688 |
| Inventories | 0 | 1.741 | 2.429 | 0 | 5.056 | 4.960 | 4.850 | 4.865 | 4.850 | 0 |
| Receivables | 0 | 472 | 582 | 8.596 | 3.115 | 517 | 506 | 507 | 506 | 503 |
| Cash | 26.785 | 4.027 | 1.532 | 19.640 | 1.093 | 421 | 251 | 186 | 180 | 185 |
| Shareholders Funds | 33.583 | 27.348 | 25.698 | 38.748 | 20.204 | 19.347 | 18.760 | 3.397 | 3.381 | -1.725 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 18.766 | 1.547 | 1.116 | 10.505 | 7.196 | 4.345 | 4.245 | 4.258 | 4.245 | 2.412 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4120 - 4120" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Conas Bioana S.r.l.